| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.21B | $4.30B | $4.02B |
| YoY Revenue Growth % | -2.0% | +6.8% | — |
| Gross Profit | $1.61B | $1.67B | — |
| Gross Margin % | 38.3% | 38.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $289.2M | $536.7M | $386.2M |
| Operating Margin % | 6.9% | 12.5% | 9.6% |
| Net Income (GAAP) | $161.4M | $316.9M | $217.1M |
| EBITDA (Normalized) | $425.1M | $646.1M | $531.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $438.0M | $741.3M | $521.7M |
| Capital Expenditures (CapEx) | $169.8M | $136.7M | $181.0M |
| Free Cash Flow (FCF) | $268.1M | $604.6M | $340.6M |
| FCF Margin % | 6.4% | 14.1% | 8.5% |
| Return on Invested Capital (ROIC %) | 6.6% | 12.4% | 7.7% |
| Cash & Short-Term Equivalents | $341.4M | $281.3M | — |
| Total Debt (Short + Long Term) | $1.19B | $1.21B | $1.54B |
| Total Stockholders' Equity | $2.63B | $2.49B | $3.17B |